Add Yahoo as a preferred source to see more of our stories on Google. A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of ...

The term smoker's cough often suggests mere hoarseness and a scratchy throat. This also refers to a persistent tickle and irritation inside one's lungs. However, doctors caution that such a chronic ...

An inhalable drug treatment for chronic obstructive pulmonary disease received FDA-approval June 26, drugmaker Verona Pharma announced. It is the first FDA-approved treatment for COPD in more than two ...

Please provide your email address to receive an email when new articles are posted on . A cough score was used to determine severity and featured questions from three validated assessments. Poorer ...

Milan, Italy: For the first time, researchers have shown it is possible to repair damaged lung tissue in patients with chronic obstructive pulmonary disease (COPD) using the patients’ own lung cells.

Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...

Chronic obstructive pulmonary disease (COPD) is a chronic, incurable condition, which is the third leading cause of death in the U.S. People with COPD experience shortness of breath, wheezing, and ...

When you think about diseases that affect the lungs, like chronic obstructive pulmonary disease (COPD), there are likely some warning signs you already know, such as frequent wheezing and coughing.

In 2021, an estimated 14 million adults in the United States reported a diagnosis of chronic obstructive pulmonary disease (COPD), chronic bronchitis, or emphysema. If you’re not sure what the ...

What do Loni Anderson, Christy Turlington, King Edward VII, Johnny Carson and more than 12 million Americans have in common? They have been diagnosed with chronic obstructive pulmonary disease, or ...

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...